Trial of lesinurad in patients with gout and renal impairment.

Trial Profile

Trial of lesinurad in patients with gout and renal impairment.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Aug 2011

At a glance

  • Drugs Lesinurad (Primary)
  • Indications Gout
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Jun 2010 Currently, four patients have completed dosing, according to an Ardea Biosciences media release.
    • 19 Jun 2010 Status changed from planning to recruiting, based on an Ardea Biosciences media release.
    • 22 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top